All Stories

  1. Gleason Pattern 4 Burden and Adverse Pathology in ISUP Grade Group 2 Prostate Cancer: Implications for Active Surveillance Selection

    Article • Cancers, October 2026, MDPI AG

    Dr Lucas LR Regis

  2. European validation of the Barcelona magnetic resonance predictive model for significant prostate cancer detection in prostate biopsies

    Article • BJUI Compass, April 2026, Wiley

    Dr Lucas LR Regis

  3. Magnetic Resonance Imaging-Based Predictive Models for Clinically Significant Prostate Cancer: A Systematic Review

    Article • Cancers, September 2022, MDPI AG

    Dr Lucas LR Regis

  4. Multiparametric MRI for Staging of Prostate Cancer: A Multicentric Analysis of Predictive Factors to Improve Identification of Extracapsular Extension before Radical Prostatectomy

    Article • Cancers, August 2022, MDPI AG

    Dr Lucas LR Regis

  5. Proclarix, A New Biomarker for the Diagnosis of Clinically Significant Prostate Cancer: A Systematic Review

    Article • Molecular Diagnosis & Therapy, April 2022, Springer Science + Business Media

    Dr Lucas LR Regis

  6. Multiparametric Magnetic Resonance Imaging Grades the Aggressiveness of Prostate Cancer

    Article • Cancers, April 2022, MDPI AG

    Dr Lucas LR Regis, Professor Luis Mariano Esteban

  7. Application of One-Step Nucleic Acid Amplification (OSNA) in different cancer entities and usefulness in prostate cancer: a systematic review

    Article • BMC Cancer, April 2022, Springer Science + Business Media

    Dr Lucas LR Regis

  8. Continence definition and prognostic factors for early urinary continence recovery in posterior rhabdosphincter reconstruction after robot-assisted radical prostatectomy. Post-hoc analysis of a randomised controlled trial

    Article • Actas Urológicas Españolas (English Edition), April 2022, Elsevier

    Dr Lucas LR Regis

  9. The Barcelona Predictive Model of Clinically Significant Prostate Cancer

    Article • Cancers, March 2022, MDPI AG

    Dr Lucas LR Regis, Professor Luis Mariano Esteban

  10. Improving the Early Detection of Clinically Significant Prostate Cancer in Men in the Challenging Prostate Imaging-Reporting and Data System 3 Category

    Article • European Urology Open Science, March 2022, Elsevier

    Dr Lucas LR Regis

  11. Who with suspected prostate cancer can benefit from Proclarix after multiparametric magnetic resonance imaging?

    Article • The International Journal of Biological Markers, February 2022, SAGE Publications

    Dr Lucas LR Regis

  12. The Efficacy of Proclarix to Select Appropriate Candidates for Magnetic Resonance Imaging and Derived Prostate Biopsies in Men with Suspected Prostate Cancer

    Article • The World Journal of Men s Health, January 2022, Korean Society for Sexual Medicine and Andrology (KAMJE)

    Dr Lucas LR Regis

  13. Re: Aina Salazar, Lucas Regis, Jacques Planas, et al. A Randomised Controlled Trial to Assess the Benefit of Posterior Rhabdosphincter Reconstruction in Early Urinary Continence Recovery after Robot-assisted Radical Prostatectomy. Eur Urol Oncol. In pr...

    Article • European Urology Oncology, September 2021, Elsevier

    Dr Lucas LR Regis

  14. The current recommendation for the management of isolated high‐grade prostatic intraepithelial neoplasia

    Article • BJU International, August 2021, Wiley

    Dr Lucas LR Regis

  15. The current value of histological findings in negative prostate biopsies to predict the future risk of clinically significant prostate cancer

    Article • Actas Urológicas Españolas (English Edition), July 2021, Elsevier

    Dr Lucas LR Regis

  16. The position of urethrovesical anastomosis after robotic radical prostatectomy assessed by MRI predicts early functional recovery: A cohort analyses from a randomized clinical trial

    Article • European Journal of Radiology, April 2021, Elsevier

    Dr Lucas LR Regis

  17. A Randomised Controlled Trial to Assess the Benefit of Posterior Rhabdosphincter Reconstruction in Early Urinary Continence Recovery after Robot-assisted Radical Prostatectomy

    Article • European Urology Oncology, February 2021, Elsevier

    Dr Lucas LR Regis

  18. Prediction of clinically significant prostate cancer after negative prostate biopsy: The current value of microscopic findings

    Article • Urologic Oncology Seminars and Original Investigations, November 2020, Elsevier

    Professor Luis Mariano Esteban, Dr Lucas LR Regis

  19. Serum Luteinizing Hormone Testing Can Identify Optimal Medical Castration

    Article • European Urology Open Science, July 2020, Elsevier

    Dr Lucas LR Regis

  20. Prostatic-specific antigen density behavior according to multiparametric magnetic resonance imaging result

    Article • Urologic Oncology Seminars and Original Investigations, February 2020, Elsevier

    Dr Lucas LR Regis

  21. Variaciones de la prostatectomía radical para una recuperación de la continencia urinaria precoz: una revisión sistemática

    Article • Actas Urológicas Españolas, December 2019, Elsevier

    Dr Lucas LR Regis

  22. Who Benefits from Multiparametric Magnetic Resonance Imaging After Suspicion of Prostate Cancer?

    Article • European Urology Oncology, November 2019, Elsevier

    Dr Lucas LR Regis

  23. Las biopsias de próstata dirigidas ¿están listas para reemplazar las biopsias de próstata sistemáticas?

    Article • Actas Urológicas Españolas, October 2019, Elsevier

    Professor Luis Mariano Esteban, Dr Lucas LR Regis

  24. How to implement magnetic resonance imaging before prostate biopsy in clinical practice: nomograms for saving biopsies

    Article • World Journal of Urology, September 2019, Springer Science + Business Media

    Professor Luis Mariano Esteban, Dr Lucas LR Regis

  25. Análisis del escenario microscópico de una biopsia prostática negativa como predictor del riesgo de cáncer de próstata. Una revisión sistemática

    Article • Actas Urológicas Españolas, September 2019, Elsevier

    Dr Lucas LR Regis

  26. Valor de la proteína STAT3 como factor pronóstico en el carcinoma renal de célula clara. Revisión sistemática

    Article • Actas Urológicas Españolas, April 2019, Elsevier

    Dr Lucas LR Regis

  27. La resonancia magnética preoperatoria predice la recuperación temprana de la continencia urinaria tras la prostatectomía radical robótica

    Article • Actas Urológicas Españolas, April 2019, Elsevier

    Dr Lucas LR Regis

  28. The role of negative magnetic resonance imaging: can we safely avoid biopsy in P.I.-R.A.D.S. 2 as in P.I.-R.A.D.S. 1?

    Article • Scandinavian Journal of Urology, January 2019, Taylor & Francis

    Dr Lucas LR Regis

  29. Revisión sistemática de los métodos predictores de la funcionalidad del trasplante renal

    Article • Actas Urológicas Españolas, May 2018, Elsevier

    Dr Lucas LR Regis

  30. Serum Testosterone Levels in Prostate Cancer Patients Undergoing Luteinizing Hormone-Releasing Hormone Agonist Therapy

    Article • Clinical Genitourinary Cancer, April 2018, Elsevier

    Dr Lucas LR Regis

  31. Accuracy of serum luteinizing hormone and serum testosterone measurements to assess the efficacy of medical castration in prostate cancer patients

    Article • Journal of Biomedical Science, October 2017, Springer Science + Business Media

    Dr Lucas LR Regis

  32. Revisión sistemática de los factores pronósticos del carcinoma renal

    Article • Actas Urológicas Españolas, May 2017, Elsevier

    Dr Lucas LR Regis

  33. Métodos para cuantificar la testosterona sérica en pacientes con cáncer de próstata sometidos a castración: una revisión sistemática

    Article • Actas Urológicas Españolas, March 2017, Elsevier

    Dr Lucas LR Regis

  34. Free Testosterone During Androgen Deprivation Therapy Predicts Castration-Resistant Progression Better Than Total Testosterone

    Article • The Prostate, November 2016, Wiley

    Dr Lucas LR Regis

  35. Cambios hormonales después del tratamiento de cáncer de próstata localizado. Comparación entre radioterapia de haz externo y prostatectomía radical

    Article • Actas Urológicas Españolas, November 2016, Elsevier

    Dr Lucas LR Regis

  36. Hormonal response recovery after long-term androgen deprivation therapy in patients with prostate cancer

    Article • Scandinavian Journal of Urology, September 2016, Taylor & Francis

    Dr Lucas LR Regis

  37. Testosterone assays? Maybe your patients under ADT aren't well castrated ...

    Article • International Journal of Urology, August 2016, Wiley

    Dr Lucas LR Regis

  38. Determinación de la testosterona sérica durante la supresión androgénica en pacientes con cáncer de próstata: una revisión sistemática

    Article • Actas Urológicas Españolas, February 2016, Elsevier

    Dr Lucas LR Regis

  39. Comportamiento de la testosterona total y libre en suero como predictores del riesgo de cáncer de próstata y de su agresividad

    Article • Actas Urológicas Españolas, November 2015, Elsevier

    Dr Lucas LR Regis

  40. Simultaneous Treatment with Statins and Aspirin Reduces the Risk of Prostate Cancer Detection and Tumorigenic Properties in Prostate Cancer Cell Lines

    Article • BioMed Research International, January 2015, Hindawi Publishing Corporation

    Dr Lucas LR Regis

  41. Bone mass behavior after 1 year of different treatment strategies in prostate cancer patients subjected to androgen deprivation therapy

    Article • Rheumatology International, March 2014, Springer Science + Business Media

    Dr Lucas LR Regis

  42. Bladder Cancer in an Inguinoscrotal Vesical Hernia

    Article • Case Reports in Oncological Medicine, January 2012, Hindawi Publishing Corporation

    Dr Lucas LR Regis